Bodisen Biotech Share Discussion Threads

[bonzophil] 16/4/2007 13:36

I am a bit concerned that the results are unaudited!

[cimbom] 16/4/2007 13:17

Thats why I did not sell.

[leighbarton] 16/4/2007 12:16

Perculiar way to announce results, where are the detailed figures?

[supersturrock] 16/4/2007 11:17

Now that AMEX has washed its hands of this one, perhaps the results should be provided in Sterling !

[supersturrock] 16/4/2007 09:41

Preliminary statement today - eps $79. I make that 40P for an historic PER of sub 4.

[cimbom] 16/4/2007 08:48

Good set of results again.

Date : 16/04/2007 @ 07:46
Source : UK Regulatory (RNS and others)


Bodisen Biotech Unaudited Preliminary Results


RNS Number:8908U
Bodisen Biotech Inc
16 April 2007


Bodisen Biotech, Inc.

Preliminary Financial Results for Fiscal Year 2006


Shaanxi, China - April 16, 2007 - Bodisen Biotech, Inc. (the "Company") (OTC
Pink Sheets: BBCZ; London AIM:BODI; website: www.bodisen.com) today announced
its unaudited operating results for the fiscal year ended December 31, 2006.


The Company is pleased to announce that for the year ended December 31, 2006,
net revenue increased 41% to $43.6 million from $31.0 million for the year ended
December 31, 2005 and this is in line with the guidance provided in an
announcement released on January 8, 2007. The gross profit margin on net
revenue for the year ended December 31, 2006 was 39% compared to gross profit on
net revenue of 37% for the year ended December 31, 2005.


Net income for the year ended December 31, 2006 was $14.1 million, or $0.79 per
share ($0.78 per share diluted) (excluding any extraordinary legal and other
expenses related to the Company's Amex deficiency issue and stockholder
lawsuits), compared to net income of $7.4 million, or $0.48 per share ($0.48 per
share diluted) for the year ended December 31, 2005. This is ahead of the
guidance previously provided when the Company expected net income of $12.9
million.


Weighted average shares outstanding for 2006 were 17,966,090 (18,072,433
diluted), compared to 15,427,494 (15,589,336 diluted) for 2005.


The full audited accounts for the fiscal year ended December 31, 2006 are
expected to be available by the end of this month.


About Bodisen Biotech, Inc.


Bodisen Biotech Inc. is a leading manufacturer of liquid and organic compound
fertilizers, pesticides, insecticides and agricultural raw materials certified
by the Petroleum Chemical Industry Administrative office of China (Chemical
Petroleum Production Administrative Bureau), Shaanxi provincial government and
Chinese government. The Company is headquartered in Shaanxi province and is a
Delaware corporation. The Company's environmentally friendly "green" products
have been proven to improve soil and plant quality, and increase crop yields.


Safe Harbor Statement


This press release may contain forward-looking statements within the meaning of
the "safe harbor" provisions of the Private Securities Litigation Reform Act of
1995. These statements are based on the current expectations or beliefs of
Bodisen Biotech, Inc. management and are subject to a number of factors and
uncertainties, and the outcome of events may differ materially from those
described in the forward-looking statements, including but not limited to the
date on which the Company will file its Annual Report.


Enquiries:


Charles Stanley Securities

Richard Thompson / Philip Davies 020 7149 6000



This information is provided by RNS
The company news service from the London Stock Exchange
END

MSCGUUWCCUPMUMQ

[influence] 03/4/2007 16:17

WINS is the only market maker and when the price was £2+ the spread was 35p. Now the price is circa 75p the Market Maker spread is the same. Obviously, other orders can narrow the spread

[influence] 03/4/2007 16:17

WINS is the only market maker and when the price was £2+ the spread was 35p. Now the price is circa 75p the Market Maker spread is the same. Obviously, other orders can narrow the spread

[beta_adjusted] 03/4/2007 11:02

huge spread ... somewhat unsurprising given circumstances.

Can anyone tell me whether this is abnormally wide today or is c. 50% the norm at present?

Thanks,

B

[influence] 01/4/2007 09:00

Terrible recent announcements from this company. Shares could be worth zero.

[drewz] 31/3/2007 14:22

Interesting looking chart.

[influence] 29/3/2007 08:07

Now the stock has been delisted on AMEX it may move to the pinks in USA (home of the penny shares).

[leighbarton] 28/3/2007 12:12

...and London responds positively - very bizarre

[influence] 28/3/2007 11:51

Have now been delisted on Amex.

[influence] 23/3/2007 19:34

I dont think so...I think they have halted trades this morning in USA.

[leighbarton] 23/3/2007 17:46

influence, I think these were actually suspended at the beginning of the week, however share you sentiment on AIM's position. May be they lack the legal grounds to take action?

[influence] 23/3/2007 17:40

these shares have been suspended in USA from this morning. Am surpised that AIM have not also suspended.

[miamisteve] 23/3/2007 16:28

Despite everything, I'd say at this level if you haven't sold it's best wait and see. I had been offloading my US holdings around $5 after the q4 results but still have around a quarter.

Cash and their chng holding alone pretty much make up the market cap.

[narindg] 23/3/2007 11:30

You could have bought at 66p yesterday and sold today at 95p!

[cheeznbreed] 21/3/2007 10:54

What a disaster. I feel sorry for all the holders, total disgrace.

[professormarcos] 20/3/2007 22:55

Are condoms cheap in China....or is it best to invest in some shaggy chinese company on AIM with some condom connections?

...Level 4 has BODI marked at 4p
Hope this helps

[miamisteve] 20/3/2007 17:25

Someone asked about the lawsuit earlier.

This is the current situation.

Lawyers are waiting on judge to appoint lead plaintiff. (I have applied to be lead plaintiff as well.)

With or without delisting, the main issue is Bodisens insurance policy for this issue, which has not been revealed so far.

Otherwise UK holdings do not seem to be part of the class.

If the company are not covered by the insurance then the lawyers may go after assets or ask for issuance of equity.

[not manu] 20/3/2007 15:55

This is what I wrote when reviewing the 2006 interims last Aug.

"Beware Vendor financing. Beware Cash generation is poor. Quite aggressive revenue recognition".